期刊文献+

肝内胆管细胞癌患者的预后影响因素分析 被引量:8

Analysis of prognostic factors influencing the outcome of intrahepatic cholangiocarcinoma
原文传递
导出
摘要 目的分析影响肝内胆管细胞癌(ICC)患者预后的相关临床病理因素,并对ICC的外科治疗方式进行探讨。方法回顾性分析43例经病理证实为ICC患者的临床病理资料。43例ICC患者中,40例行肝切除术,2例在剖腹探查时行无水酒精注射,1例仅行剖腹探查。采用单因素和Cox回归模型对可能影响ICC患者术后生存的因素进行分析。结果全组43例患者的1、3和5年生存率分别为64.4%、30.9%和25.8%。40例行肝切除患者的术后1、3和5年生存率分别为74.7%、33.3%和27.8%。单因素分析结果显示,肿瘤直径、有无淋巴结转移、癌胚抗原(CEA)水平和TNM分期与ICC患者的术后生存显著相关(均P〈0.05)。Cox多因素分析结果显示,肿瘤直径和有无淋巴结转移是影响ICC患者术后生存的独立因素(均P〈0.05)。结论肿瘤直径和有无淋巴结转移是影响ICC患者术后生存的独立因素,CEA水平和TNM分期是影响ICC患者术后生存的重要因素。对ICC患者应选择行根治性肝切除术。 Objective To analyze the clinicopathologic factors influencing the outcome of surgically treated intrahepatic eholangiocareinoma (ICC) and to explore the proper treatment choice of ICC. Methods The clinicopathological data of 43 surgically treated ICC patients in our hospital were retrospectively analyzed. Of the 43 patients, hepatic resection was performed in 40 patients, ethanol injection in 2, and laparoscopie exploration alone in 1. Kaplan-Meier method and Cox regression model were used for the analysis of factors influencing survival after operation. Results The accumulative 1-, 3- and 5-year survival rates were 64.4% , 30.9% , 25.8% for the whole group, and 74.7%, 33.3%, 27.8% for the 40 patients with hepatic resection, respectively. Univariate analysis revealed that tumor size, carcinoembryonie antigen (CEA) level, lymph node involvement and TNM stage were factors significantly affecting the survival (P 〈 0.05 ). Cox multivariate analysis demonstrated that only tumor size and lymph node involvement were the independent factors significantly affecting the survival( P 〈 0.05 ). Conclusion Our results show that tumor size and lymph node involvement are independent factors affecting the survival. CEA level and TNM stage are important prognostic factors for surgical management. Radical resection is still the optimal treatment for patient with intrahepatic cholangiocarcinoma.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第11期845-848,共4页 Chinese Journal of Oncology
关键词 肝内胆管细胞癌 肝切除术 预后 Intrahepatic cholangiocarcinoma Hepatectomy Prognosis
  • 相关文献

参考文献13

  • 1Konstadoulakis MM,Roayaie S,Comatos IP,et al.Fifteen-year,singlecenter experience with the surgical management of intrahepatic cholanglocarcinoma:operative results and long-term outcome.Surgery,2008,143:366-374.
  • 2Shimada M,Yamashita Y,Aishima S,et al.Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma.Br J Surg,2001,88:1463-1466.
  • 3Okami J,Dono K,Sakon M,et al.Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe.J Gastrointest Surg,2003,7:850-856.
  • 4Nozaki Y,Yamamoto M,Ikai I,et al.Reconsideration of the lymph node metastasis pattern (N factor) from intrahepatic cholangiocarcinoma using the International Union Against Cancer TNM staging system for primary liver carcinoma.Cancer,1998,83:1923-1929.
  • 5Uenishi T,Kube S,Yamazaki O,et al.Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.J Hepatobiliary Pancreat Surg,2008,15:417-422.
  • 6Grobmyer SR,Wang L,Gonen M,et al.Perihepatic lymph node assessment in patients undergoing partial hepatectomy for malignancy.Ann Surg,2006,244:260-264.
  • 7Urahashi T,Yamamoto M,Ohtsubo T,et al.Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.Hepatogastrcenterology,2007,54:346-349.
  • 8Nakagohri T,Kinoshita T,Konishi M,et al.Surgical outcome and prognostic factors in intrahepatic cholanglocarcinoma.World J Surg,2008,32:2675-2680.
  • 9Gomez D,Morris-Stiff G,Toogood GJ,et al.Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.J Surg Oncol,2008,97:513-518.
  • 10Yedibela S,Demir R,Zhang W,et al.Surgical treatment of massforming intrahepatic cholangiocarcinoma:an 11 -year Western single-center experience in 107 patients.Ann Surg Oncol,2009,16:404-412.

同被引文献86

  • 1王曙光,韩本立,陈意生,彭志明,贺光友.胆管癌转移途径的病理学研究[J].中华外科杂志,1996,34(6):352-354. 被引量:38
  • 2陈中,晏建军,黄亮,吴孟超,严以群.肝内胆管细胞癌淋巴结转移与预后的关系[J].中华外科杂志,2006,44(7):454-457. 被引量:12
  • 3王晓明,胡士杰,吴健雄,荣维淇,王黎明.41例肝内胆管细胞癌的临床特点及其预后观察[J].中国肿瘤临床,2006,33(15):874-876. 被引量:5
  • 4陈中,晏建军,黄亮,吴孟超,严以群.肝内胆管细胞癌预后因素分析[J].中华肝胆外科杂志,2006,12(10):654-656. 被引量:12
  • 5屠金夫,黄秀芳,朱冠保,李剑敏,蒋飞照,张启瑜.胆管乳头状瘤14例的临床病理及外科治疗[J].中华普通外科杂志,2007,22(6):420-423. 被引量:10
  • 6陈中 晏建军 黄亮 等.肝内胆管细胞癌淋巴结转移与预后的关系.中华肝胆外科杂志,2010,12(10):656-656.
  • 7Szudek J,Taylor SM. Systematic review of the Platysma Myocu- taneous flap for head and neck reconstruction[J]. Arch Otolayn- gol Head Neck Surg,2007,133(7) :655-661.
  • 8Akiba J,Nakashima O, Hattori S, et al. Clinicopathologic analy- sis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification[J]. Am J Surg Pathol, 2013,37 (4) :496-505.
  • 9De Campos RO, Semelka RC, Azevedo RM, et al. Combined hep- atocellular carcinoma-cholangiocareinoma: report of MR appear- ance in eleven patients[J]. J Magn Reson Imaging, 2012,36 ( 5 ) 1139-1147.
  • 10Yin X,Zhang BH,Qiu SJ,et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis[J]. Ann Surg Oncol,2012,19(9) :2869-2876.

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部